BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 8904929)

  • 1. Soluble CD8 antigen, stimulated C-peptide and islet cell antibodies are predictors of insulin requirement in newly diagnosed patients with unclassifiable diabetes.
    Di Bonito P; De Bellis A; Capaldo B; Turco S; Corigliano G; Pace E; Bizzarro A
    Acta Diabetol; 1996 Sep; 33(3):220-4. PubMed ID: 8904929
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Islet cell antibodies and fasting C-peptide predict insulin requirement at diagnosis of diabetes mellitus.
    Landin-Olsson M; Nilsson KO; Lernmark A; Sundkvist G
    Diabetologia; 1990 Sep; 33(9):561-8. PubMed ID: 2253834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-cell function in relation to islet cell antibodies during the first 3 yr after clinical diagnosis of diabetes in type II diabetic patients.
    Gottsäter A; Landin-Olsson M; Fernlund P; Lernmark A; Sundkvist G
    Diabetes Care; 1993 Jun; 16(6):902-10. PubMed ID: 8325204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationships among islet cell antibodies, residual beta-cell function, and metabolic control in patients with insulin-dependent diabetes mellitus of long duration: use of a sensitive C-peptide radioimmunoassay.
    Nakanishi K; Kobayashi T; Miyashita H; Ohkubo M; Sugimoto T; Murase T; Kosaka K; Inouye K; Kono M
    Metabolism; 1990 Sep; 39(9):925-30. PubMed ID: 2202883
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of a short prednisone regime at clinical onset of type 1 diabetes.
    Goday A; Pujol-Borrell R; Fernandez J; Casamitjana R; Rios M; Vilardell E; Gomis R
    Diabetes Res Clin Pract; 1993 Apr; 20(1):39-46. PubMed ID: 8344127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age, sex and ICA influence on beta-cell secretion during the first year after the diagnosis of type 1 diabetes mellitus.
    Montaña E; Fernandez-Castañer M; Rosel P; Gomez J; Soler J
    Diabete Metab; 1991; 17(5):460-8. PubMed ID: 1752347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GAD antibodies in NIDDM. Ten-year follow-up from the diagnosis.
    Niskanen LK; Tuomi T; Karjalainen J; Groop LC; Uusitupa MI
    Diabetes Care; 1995 Dec; 18(12):1557-65. PubMed ID: 8722051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes.
    Groop L; Miettinen A; Groop PH; Meri S; Koskimies S; Bottazzo GF
    Diabetes; 1988 Jan; 37(1):99-103. PubMed ID: 3275559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors predicting residual beta-cell function in the first year after diagnosis of childhood type 1 diabetes.
    Couper JJ; Hudson I; Werther GA; Warne GL; Court JM; Harrison LC
    Diabetes Res Clin Pract; 1991 Jan; 11(1):9-16. PubMed ID: 2019237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunogenetic and nutritional profile in insulin-using youth-onset diabetics in Korea.
    Huh KB; Lee HC; Kim HM; Cho YW; Kim YL; Lee KW; Lee EJ; Lim SK; Kim DH; Yoon JW
    Diabetes Res Clin Pract; 1992 Apr; 16(1):63-70. PubMed ID: 1576933
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of predictive value of islet cell antibodies, insulin antibodies, and HLA-DR phenotype for remission in cyclosporin-treated IDDM patients. The Canadian-European Randomized Control Trial Group.
    Mandrup-Poulsen T; Mølvig J; Andersen HU; Helqvist S; Spinas GA; Munck M
    Diabetes; 1990 Feb; 39(2):204-10. PubMed ID: 2227128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictive value of human leukocyte antigen class II typing for the development of islet autoantibodies and insulin-dependent diabetes postpartum in women with gestational diabetes.
    Ferber KM; Keller E; Albert ED; Ziegler AG
    J Clin Endocrinol Metab; 1999 Jul; 84(7):2342-8. PubMed ID: 10404800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Islet cell antibodies, but not glutamic acid decarboxylase antibodies, are decreased by plasmapheresis in patients with newly diagnosed insulin-dependent diabetes mellitus.
    Sundkvist G; Hagopian WA; Landin-Olsson M; Lernmark A; Ohlsson L; Ericsson C; Ahlmén J
    J Clin Endocrinol Metab; 1994 May; 78(5):1159-65. PubMed ID: 8175973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Islet-cell antibodies and endogenous insulin secretion in Sudanese diabetic children.
    Elamin A; Omer MI; Tuvemo T
    Diabetes Res Clin Pract; 1992 May; 16(2):91-6. PubMed ID: 1600856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Islet cell antibodies (ICA), insulin autoantibodies (IAA), islet cell surface antibodies (ICSA) and C-peptide in 1031 school children in a population with a high background incidence of IDDM.
    Samuelsson U; Ludvigsson J; Sundkvist G
    Diabetes Res Clin Pract; 1994 Dec; 26(3):155-62. PubMed ID: 7736895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glutamic acid decarboxylase antibodies in relation to other autoantibodies and genetic risk markers in children with newly diagnosed insulin-dependent diabetes. Childhood Diabetes in Finland Study Group.
    Sabbah E; Kulmala P; Veijola R; Vähäsalo P; Karjalainen J; Tuomilehto-Wolf E; Akerblom HK; Knip M
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2455-9. PubMed ID: 8675560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Types of pediatric diabetes mellitus defined by anti-islet autoimmunity and random C-peptide at diagnosis.
    Redondo MJ; Rodriguez LM; Escalante M; Smith EO; Balasubramanyam A; Haymond MW
    Pediatr Diabetes; 2013 Aug; 14(5):333-40. PubMed ID: 23458188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.
    Chaillous L; Lefèvre H; Thivolet C; Boitard C; Lahlou N; Atlan-Gepner C; Bouhanick B; Mogenet A; Nicolino M; Carel JC; Lecomte P; Maréchaud R; Bougnères P; Charbonnel B; Saï P
    Lancet; 2000 Aug; 356(9229):545-9. PubMed ID: 10950231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Islet-cell antibodies: markers of a more severe insulin-dependent diabetes mellitus?
    Montaña E; Goday A; Rosel P; Casamitjana R; Soler J; Gomis R
    Diabetes Res; 1989 Aug; 11(4):167-71. PubMed ID: 2625032
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.